TY  - JOUR
AU  - van der Wouden, Cathelijne H
AU  - Bohringer, Stefan
AU  - Cecchin, Erika
AU  - Cheung, Ka-Chun
AU  - Davila-Fajardo, Cristina Lucía
AU  - Deneer, Vera H M
AU  - Dolžan, Vita
AU  - Ingelman-Sundberg, Magnus
AU  - Jonsson, Siv
AU  - Karlsson, Mats O
AU  - Kriek, Marjolein
AU  - Mitropoulou, Christina
AU  - Patrinos, George P
AU  - Pirmohamed, Munir
AU  - Rial-Sebbag, Emmanuelle
AU  - Samwald, Matthias
AU  - Schwab, Matthias
AU  - Steinberger, Daniela
AU  - Stingl, Julia
AU  - Sunder-Plassmann, Gere
AU  - Toffoli, Giuseppe
AU  - Turner, Richard M
AU  - van Rhenen, Mandy H
AU  - van Zwet, Erik
AU  - Swen, Jesse J
AU  - Guchelaar, Henk-Jan
AU  - Ubiquitous Pharmacogenomics Consortium
PY  - 2020
DO  - 10.1097/FPC.0000000000000405
UR  - http://hdl.handle.net/10668/15406
T2  - Pharmacogenetics and genomics
AB  - Pharmacogenetic panel-based testing represents a new model for precision medicine. A sufficiently powered prospective study assessing the (cost-)effectiveness of a panel-based pharmacogenomics approach to guide pharmacotherapy is lacking. Therefore,...
LA  - en
PB  - Lippincott Williams & Wilkins
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Evidence-Based Medicine
KW  - Humans
KW  - Models, Statistical
KW  - Pharmacogenomic Testing
KW  - Practice Guidelines as Topic
KW  - Precision Medicine
KW  - Prospective Studies
TI  - Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study.
TY  - research article
VL  - 30
ER  -